Guardant Health, Inc. (GH) Costs and Expenses USD 2017 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Guardant Health, Inc. quarterly/annual Costs and Expenses history and growth rate from 2017 to 2024.
Guardant Health, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $268 M, a 2.06% increase year-over-year.
Guardant Health, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $1.13 B, a 9.34% increase year-over-year.
Guardant Health, Inc. annual Costs and Expenses for 2023 was $1.13 B, a 13.6% increase from 2022.
Guardant Health, Inc. annual Costs and Expenses for 2022 was $994 M, a 26.7% increase from 2021.
Guardant Health, Inc. annual Costs and Expenses for 2021 was $785 M, a 44.9% increase from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$1.13 B	$268 M	+$5.41 M	+2.06%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$1.13 B	$353 M	+$79.6 M	+29.1%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	$1.05 B	$257 M	-$5.43 M	-2.07%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$1.05 B	$257 M	+$17.3 M	+7.23%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$1.04 B	$263 M	+$43.3 M	+19.7%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$994 M	$273 M	+$66.7 M	+32.3%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$927 M	$262 M	+$59.9 M	+29.7%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-06
Q2 2022	$867 M	$239 M	+$49.7 M	+26.2%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$818 M	$219 M	+$32.9 M	+17.6%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	$785 M	$206 M	+$36.8 M	+21.7%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-22
Q3 2021	$748 M	$202 M	+$53.2 M	+35.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$695 M	$190 M	+$68.8 M	+56.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$626 M	$187 M	+$84.1 M	+82.1%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$542 M	$169 M	+$80.6 M	+90.7%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-23
Q3 2020	$461 M	$149 M	+$70.5 M	+90%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$391 M	$121 M	+$51.7 M	+74.7%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$339 M	$102 M	+$42.1 M	+69.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$297 M	$88.9 M	+$28.6 M	+47.5%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-24
Q3 2019	$268 M	$78.3 M	+$32.4 M	+70.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$236 M	$69.2 M	+$27.2 M	+64.5%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$209 M	$60.3 M	+$25 M	+70.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$184 M	$60.3 M			Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018		$45.9 M	+$6.09 M	+15.3%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		$42.1 M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018		$35.3 M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q3 2017		$39.8 M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.